In the trial, and I know this from researching ind
Post# of 148184
With leronlimab, Dr. Patterson said they thought they could determine R5 immediately, and also receptor occupancy. If he was successful, maybe they can get leronlimab in the patient within the first few days.
Also with leronlimab, you get the added bonus of personalized feedback from NP (from 2016)
https://www.dailymail.co.uk/health/article-39...trial.html